Familial pulmonary arterial hypertension by


Journal

The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460

Informations de publication

Date de publication:
04 2020
Historique:
received: 07 11 2019
accepted: 02 01 2020
pubmed: 26 1 2020
medline: 22 6 2021
entrez: 26 1 2020
Statut: epublish

Résumé

Beyond the major gene

Identifiants

pubmed: 31980491
pii: 13993003.02165-2019
doi: 10.1183/13993003.02165-2019
pii:
doi:

Substances chimiques

KDR protein, human EC 2.7.10.1
Vascular Endothelial Growth Factor Receptor-2 EC 2.7.10.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : British Heart Foundation
ID : CH/09/001/25945
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K020919/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright ©ERS 2020.

Déclaration de conflit d'intérêts

Conflict of interest: M. Eyries has nothing to disclose. D. Montani reports grants and personal fees from Actelion and Bayer, personal fees from GSK, Pfizer and MSD, outside the submitted work. Conflict of interest: B. Girerd has nothing to disclose. Conflict of interest: N. Favrolt has nothing to disclose. Conflict of interest: M. Riou has nothing to disclose. Conflict of interest: L. Faivre has nothing to disclose. Conflict of interest: G. Manaud has nothing to disclose. Conflict of interest: F. Perros has nothing to disclose. Conflict of interest: S. Gräf has nothing to disclose. Conflict of interest: M.W. Morrell is an employee of Morphogen-IX. Conflict of interest: M. Humbert reports personal fees from Acceleron, Actelion, Merck and United Therapeutics, grants and personal fees from Bayer and GSK, outside the submitted work. Conflict of interest: F. Soubrier has nothing to disclose.

Auteurs

Mélanie Eyries (M)

Hôpital Pitié-Salpêtrière, Département de génétique, Assistance Publique-Hôpitaux de Paris, Paris, France.
UMR_S1166-ICAN, Sorbonne Université, INSERM, Paris, France.
Equally contributing authors.

David Montani (D)

Univ. Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin Bicêtre, France.
Assistance Publique Hôpitaux de Paris, Service de Pneumologie, Centre de Référence de l'Hypertension Pulmonaire, Hôpital Bicêtre, Le Kremlin Bicêtre, France.
UMR_S 999, Univ. Paris-Sud, INSERM, Hôpital Marie Lannelongue, Le Plessis Robinson, France.
Equally contributing authors.

Barbara Girerd (B)

Univ. Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin Bicêtre, France.
Assistance Publique Hôpitaux de Paris, Service de Pneumologie, Centre de Référence de l'Hypertension Pulmonaire, Hôpital Bicêtre, Le Kremlin Bicêtre, France.

Nicolas Favrolt (N)

Service de Pneumologie et Soins Intensifs Respiratoires, Centre de référence constitutif des maladies pulmonaires rares de l'adulte, Centre de compétence de l'hypertension pulmonaire, CHU Dijon-Bourgogne, Dijon, France.

Marianne Riou (M)

Service de pneumologie, Nouvel hôpital civil, Strasbourg, France.

Laurence Faivre (L)

Centre de génétique, FHU TRANSLAD, Institut GIMI et UMR INSERM 1231, CHU de Dijon et Université de Bourgogne, Dijon, France.

Grégoire Manaud (G)

UMR_S 999, Univ. Paris-Sud, INSERM, Hôpital Marie Lannelongue, Le Plessis Robinson, France.

Frédéric Perros (F)

UMR_S 999, Univ. Paris-Sud, INSERM, Hôpital Marie Lannelongue, Le Plessis Robinson, France.

Stefan Gräf (S)

NIHR Bioresource - Rare Diseases, Cambridge Biomedical Campus, Cambridge, UK.
Dept of Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
Dept of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.

Nicholas W Morrell (NW)

NIHR Bioresource - Rare Diseases, Cambridge Biomedical Campus, Cambridge, UK.
Dept of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's and Royal Papworth Hospitals, Cambridge, UK.

Marc Humbert (M)

Univ. Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin Bicêtre, France.
Assistance Publique Hôpitaux de Paris, Service de Pneumologie, Centre de Référence de l'Hypertension Pulmonaire, Hôpital Bicêtre, Le Kremlin Bicêtre, France.
UMR_S 999, Univ. Paris-Sud, INSERM, Hôpital Marie Lannelongue, Le Plessis Robinson, France.

Florent Soubrier (F)

Hôpital Pitié-Salpêtrière, Département de génétique, Assistance Publique-Hôpitaux de Paris, Paris, France florent.soubrier@sorbonne-universite.fr.
UMR_S1166-ICAN, Sorbonne Université, INSERM, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH